Year |
Citation |
Score |
2023 |
Moos WH, Faller DV, Glavas IP, Kanara I, Kodukula K, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG. Epilepsy: Mitochondrial Connections to the 'Sacred' Disease. Mitochondrion. PMID 37582467 DOI: 10.1016/j.mito.2023.08.002 |
0.56 |
|
2022 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Tamvakopoulos C, et al. Treatment and Prevention of Pathological Mitochondrial Dysfunction in Retinal Degeneration and in Photoreceptor Injury. Biochemical Pharmacology. 115168. PMID 35835206 DOI: 10.1016/j.bcp.2022.115168 |
0.596 |
|
2021 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, et al. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochemical Pharmacology. 193: 114809. PMID 34673016 DOI: 10.1016/j.bcp.2021.114809 |
0.59 |
|
2020 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG, Zamboni RJ, Kodukula K, et al. Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Bioresearch Open Access. 9: 94-105. PMID 32257625 DOI: 10.1089/Biores.2020.0004 |
0.624 |
|
2019 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG, Kodukula K, Zamboni RJ. Epigenetic treatment of dermatologic disorders Drug Development Research. 80: 702-713. DOI: 10.1002/Ddr.21562 |
0.557 |
|
2018 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. A New Approach to Treating Neurodegenerative Otologic Disorders. Bioresearch Open Access. 7: 107-115. PMID 30069423 DOI: 10.1089/Biores.2018.0017 |
0.626 |
|
2017 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Bioresearch Open Access. 6: 169-181. PMID 29291141 DOI: 10.1089/Biores.2017.0036 |
0.615 |
|
2017 |
Kodukula K, Faller DV, Harpp DN, Kanara I, Pernokas J, Pernokas M, Powers WR, Soukos NS, Steliou K, Moos WH. Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. Bioresearch Open Access. 6: 123-132. PMID 29098118 DOI: 10.1089/Biores.2017.0020 |
0.571 |
|
2016 |
Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K. Epigenetic Treatment of Persistent Viral Infections. Drug Development Research. PMID 27761936 DOI: 10.1002/Ddr.21366 |
0.613 |
|
2014 |
Anderson DC, Kodukula K. Biomarkers in pharmacology and drug discovery. Biochemical Pharmacology. 87: 172-88. PMID 24001556 DOI: 10.1016/J.Bcp.2013.08.026 |
0.36 |
|
2013 |
Perrone JB, Kodukula K, Moos WH. Biomarkers-An Essential Tie That Binds the Future of Drugs and Diagnostics Drug Development Research. 74: 63-64. DOI: 10.1002/Ddr.21071 |
0.562 |
|
2013 |
Jambunathan K, Welsh GI, Kodukula K, Saleem MA, Galande AK. Proteolytic enzymes as biomarkers of focal segmental glomerulosclerosis Drug Development Research. 74: 81-91. DOI: 10.1002/Ddr.21062 |
0.316 |
|
2012 |
Jambunathan K, Watson DS, Kodukula K, Galande AK. Proteolytic fingerprinting of complex biological samples using combinatorial libraries of fluorogenic probes. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit21.22. PMID 23151745 DOI: 10.1002/0471140864.Ps2122S70 |
0.317 |
|
2012 |
Jambunathan K, Watson DS, Endsley AN, Kodukula K, Galande AK. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α. Febs Letters. 586: 2507-12. PMID 22750443 DOI: 10.1016/J.Febslet.2012.06.015 |
0.336 |
|
2012 |
Moos WH, Kodukula K. Nonprofit pharma: solutions to what ails the industry. Current Medicinal Chemistry. 18: 3437-40. PMID 21728955 DOI: 10.2174/092986711796504763 |
0.543 |
|
2011 |
Sarker M, Chopra S, Mortelmans K, Kodukula K, Talcott C, Gal AK. In Silico Pathway Analysis Predicts Metabolites that are Potential Antimicrobial Targets Journal of Computer Science & Systems Biology. 4: 21-26. DOI: 10.4172/Jcsb.1000071 |
0.317 |
|
2011 |
Song B, Galande AK, Kodukula K, Moos WH, Miller SM. Evaluation of the pKa values and ionization sequence of bumetanide using 1H and 13C NMR and UV spectroscopy Drug Development Research. 72: 416-426. DOI: 10.1002/Ddr.20443 |
0.541 |
|
2009 |
Vaidyanathan R, Kodukula K. Using a systems biology approach to dissect parasite-host interactions Drug Development Research. 70: 296-302. DOI: 10.1002/Ddr.20307 |
0.309 |
|
Show low-probability matches. |